PAROOL KADAKIA: Open Payments
NPI 1437120698 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 69 payments from 26 companies in 2025. Trend: 2023 $2,044 · 2024 $1,805 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $267 |
| AstraZeneca Pharmaceuticals LP | 6 | $201 |
| PFIZER INC. | 8 | $166 |
| Lilly USA, LLC | 4 | $75 |
| Novo Nordisk Inc | 4 | $70 |
| Astellas Pharma US Inc | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Merck Sharp & Dohme LLC | 2 | $41 |
Products named: UBRELVY, FARXIGA, JARDIANCE, NURTEC ODT, VRAYLAR, Veozah, QULIPTA, Kerendia.
Industry payments across OH — which companies pay providers there.
